bpc-157 human clinical trials safety adverse events — the most prescribed peptide you've never seen in a trial. 30 total subjects. Zero RCTs. A Phase 1 that was registered, enrolled, and then quietly canceled with no Label:Blue

CJC-1295 & Ipamorelin Orlando | Growth Hormone Peptide Therapy

We use lab testing to assess nutrient levels , methylation markers, and underlying contributors like adrenal or thyroid function, then customize your care for maximum effect and safety

skin brightening

Label:Blue

Repeated dosing studies in rats, dogs, and mice for up to 6 weeks across doses from 0.006 mg/kg to 20 mg/kg via multiple routes showed excellent tolerance